0.6799
price up icon0.00%   0.00
 
loading

Gt Biopharma Inc Aktie (GTBP) Neueste Nachrichten

pulisher
09:45 AM

Will GT Biopharma Inc. stock benefit from automationM&A Rumor & Long-Term Safe Investment Ideas - newser.com

09:45 AM
pulisher
09:04 AM

Tools to assess GT Biopharma Inc.’s risk profile2025 Market Outlook & Momentum Based Trading Ideas - newser.com

09:04 AM
pulisher
05:27 AM

Visual trend scoring systems applied to GT Biopharma Inc.Earnings Overview Summary & Low Drawdown Momentum Trade Ideas - newser.com

05:27 AM
pulisher
05:14 AM

Strategies to average down on GT Biopharma Inc.Fed Meeting & Safe Entry Zone Tips - newser.com

05:14 AM
pulisher
05:08 AM

Will GT Biopharma Inc. continue its uptrendQuarterly Market Summary & Advanced Swing Trade Entry Alerts - newser.com

05:08 AM
pulisher
Oct 12, 2025

GT Biopharma Inc OXIA Stock Analysis and ForecastEconomic Data Impact & Investment Recommendations You Can Trust - earlytimes.in

Oct 12, 2025
pulisher
Oct 10, 2025

Chart based analysis of GT Biopharma Inc. trendsStop Loss & Weekly High Potential Stock Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Using economic indicators to assess GT Biopharma Inc. potentialMarket Growth Summary & Breakout Confirmation Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

GT Biopharma Inc. stock volume spike explainedPortfolio Growth Summary & AI Driven Stock Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will GT Biopharma Inc. (OXIA) stock test record highs in 2025Quarterly Trade Report & Trade Opportunity Analysis Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

GT Biopharma Inc. stock trend forecastWeekly Profit Report & Fast Moving Market Watchlists - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Why GT Biopharma Inc. stock is seen as undervaluedPortfolio Performance Report & Long-Term Growth Portfolio Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

GT Biopharma Stock Logs Best Session In Over 9 Months On Promising Cancer Trial Data; Retail Eyes Double-Digit Rally - Stocktwits

Oct 09, 2025
pulisher
Oct 09, 2025

Using data filters to optimize entry into GT Biopharma Inc.Insider Selling & Consistent Profit Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

GT Biopharma advances Phase 1 trial of NK cell therapy with no safety issues - Investing.com Nigeria

Oct 08, 2025
pulisher
Oct 08, 2025

Stocks In Play: GT Biopharma Inc - Barchart.com

Oct 08, 2025
pulisher
Oct 08, 2025

Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034 - 富途牛牛

Oct 08, 2025
pulisher
Oct 08, 2025

GT Biopharma provides enrollment update on GTB-3650 Phase 1 trial in patients with relapsed or refractory (R/R) CD33 expressing hematologic malignancies - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

GT Biopharma Reports Successful Phase 1 Trial Progress for GTB-3650 in Hematologic Malignancies - Quiver Quantitative

Oct 08, 2025
pulisher
Oct 08, 2025

GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 - GlobeNewswire

Oct 08, 2025
pulisher
Oct 08, 2025

GT Biopharma Initiates Cohort 3 Dosing; No DLTs, Cohort 4 Planned | GTBP Stock News - Stock Titan

Oct 08, 2025
pulisher
Oct 08, 2025

EXCLUSIVE: GT Biopharma Reports Progresses Phase 1 Trial Of Lead Drug Candidate For Blood Cancers - Yahoo Finance

Oct 08, 2025
pulisher
Oct 08, 2025

GT Biopharma Inc - Menafn.com

Oct 08, 2025
pulisher
Oct 07, 2025

Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion - MarketScreener

Oct 07, 2025
pulisher
Oct 07, 2025

Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms - Eastern Progress

Oct 07, 2025
pulisher
Oct 06, 2025

Precision Oncology Pipeline Advances from Detection Through Targeted Destruction - The Globe and Mail

Oct 06, 2025
pulisher
Oct 06, 2025

GT Biopharma to Participate in the Centurion One Capital 3rd Annual Bahamas Summit - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

Oct 28–29: GT Biopharma CEO Michael Breen to Attend Bahamas Summit; One-on-one Meetings Available - Stock Titan

Oct 06, 2025
pulisher
Oct 05, 2025

Key metrics from GT Biopharma Inc.’s quarterly dataBond Market & Weekly Momentum Stock Picks - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How GT Biopharma Inc. (OXIA) stock reacts to new regulationsJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What’s the recovery path for long term holders of GT Biopharma Inc.Market Volume Summary & Expert Curated Trade Setups - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What drives GT Biopharma Inc stock priceChart Pattern Recognition & Small Capital Trading Growth - earlytimes.in

Oct 05, 2025
pulisher
Oct 03, 2025

Will GT Biopharma Inc. (OXIA) stock profit from automation wave2025 Key Highlights & High Accuracy Buy Signal Tips - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

GT Biopharma Inc Stock Analysis and ForecastHead and Shoulders Patterns & Set Your Capital Stop-Loss Limits Effectively - earlytimes.in

Oct 02, 2025
pulisher
Sep 30, 2025

Can swing trading help recover from GT Biopharma Inc. lossesTrade Analysis Summary & AI Enhanced Market Trend Forecasts - newser.com

Sep 30, 2025
$84.76
price up icon 1.09%
$22.86
price up icon 7.26%
$32.59
price up icon 2.39%
$102.83
price up icon 0.77%
$165.92
price up icon 2.24%
biotechnology ONC
$330.21
price up icon 3.42%
Kapitalisierung:     |  Volumen (24h):